本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioCryst制药

8.55
0.0000
盘后8.550.0021+0.02%18:41 EDT
成交量:236.41万
成交额:2,024.91万
市值:17.89亿
市盈率:-32.95
高:8.64
开:8.53
低:8.50
收:8.55
数据加载中...
2020/05/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/17

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/04/10

重要事件披露

8-K - Current report
2020/04/02

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2020/03/30

重要事件披露

Current report, items 8.01 and 9.01
2020/03/13

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

重要事件披露

Current report, item 1.02
2020/03/05

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2020/03/05

重要事件披露

Current report, items 8.01 and 9.01
2020/02/25

重要事件披露

Current report, items 5.02 and 9.01
2020/02/18

重要事件披露

Current report, items 8.01 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

重要事件披露

Current report, items 8.01 and 9.01